drugs

Faculty members in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, share their research on the human microbiome and microfabricated drug delivery systems and their hopes for how their science will improve the health of patients.

UCSF's Small Molecule Discovery Center (SMDC) announced on February 18, 2010 that it has signed its first major industry partnership agreement since the SMDC was founded in 2005. The agreement is with Genentech, Inc. to discover and develop drug candidates for neurodegenerative diseases.

Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.